GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exelixis Inc (LTS:0IJO) » Definitions » Shiller PE Ratio

Exelixis (LTS:0IJO) Shiller PE Ratio : 49.88 (As of Mar. 03, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Exelixis Shiller PE Ratio?

As of today (2025-03-03), Exelixis's current share price is $37.91. Exelixis's E10 for the quarter that ended in Dec. 2024 was $0.76. Exelixis's Shiller PE Ratio for today is 49.88.

The historical rank and industry rank for Exelixis's Shiller PE Ratio or its related term are showing as below:

LTS:0IJO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 38.77   Med: 79.4   Max: 690.67
Current: 51.83

During the past years, Exelixis's highest Shiller PE Ratio was 690.67. The lowest was 38.77. And the median was 79.40.

LTS:0IJO's Shiller PE Ratio is ranked worse than
66.67% of 132 companies
in the Biotechnology industry
Industry Median: 34.25 vs LTS:0IJO: 51.83

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Exelixis's adjusted earnings per share data for the three months ended in Dec. 2024 was $0.480. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.76 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Exelixis Shiller PE Ratio Historical Data

The historical data trend for Exelixis's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exelixis Shiller PE Ratio Chart

Exelixis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 122.92 64.32 44.61

Exelixis Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.32 53.53 39.21 39.47 44.61

Competitive Comparison of Exelixis's Shiller PE Ratio

For the Biotechnology subindustry, Exelixis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exelixis's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exelixis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Exelixis's Shiller PE Ratio falls into.



Exelixis Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Exelixis's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=37.91/0.76
=49.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exelixis's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Exelixis's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.48/133.1571*133.1571
=0.480

Current CPI (Dec. 2024) = 133.1571.

Exelixis Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.180 99.621 -0.241
201506 -0.220 100.684 -0.291
201509 -0.210 100.392 -0.279
201512 -0.190 99.792 -0.254
201603 -0.260 100.470 -0.345
201606 -0.150 101.688 -0.196
201609 -0.040 101.861 -0.052
201612 0.120 101.863 0.157
201703 0.050 102.862 0.065
201706 0.060 103.349 0.077
201709 0.260 104.136 0.332
201712 0.120 104.011 0.154
201803 0.370 105.290 0.468
201806 0.280 106.317 0.351
201809 0.410 106.507 0.513
201812 1.150 105.998 1.445
201903 0.240 107.251 0.298
201906 0.250 108.070 0.308
201909 0.310 108.329 0.381
201912 0.220 108.420 0.270
202003 0.150 108.902 0.183
202006 0.210 108.767 0.257
202009 -0.100 109.815 -0.121
202012 0.090 109.897 0.109
202103 0.005 111.754 0.006
202106 0.300 114.631 0.348
202109 0.120 115.734 0.138
202112 0.290 117.630 0.328
202203 0.210 121.301 0.231
202206 0.220 125.017 0.234
202209 0.230 125.227 0.245
202212 -0.090 125.222 -0.096
202303 0.120 127.348 0.125
202306 0.250 128.729 0.259
202309 0.003 129.860 0.003
202312 0.270 129.419 0.278
202403 0.120 131.776 0.121
202406 0.770 132.554 0.774
202409 0.400 133.029 0.400
202412 0.480 133.157 0.480

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Exelixis  (LTS:0IJO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Exelixis Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Exelixis's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Exelixis Business Description

Traded in Other Exchanges
Address
1851 Harbor Bay Parkway, Alameda, CA, USA, 94502
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Exelixis Headlines

No Headlines